Related Experiment Videos
Characterization and modulation of immune stimulation by modified oligonucleotides
Antisense & Nucleic Acid Drug Development
|November 15, 1997
Summary
Oligodeoxynucleotides (ODNs) containing CpG motifs stimulate immune cells. Modifications to ODN sequences and backbones significantly impact their ability to activate natural killer (NK) and B lymphocytes.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Oligodeoxynucleotides (ODNs) are short DNA sequences with immunomodulatory potential.
- The CpG motif within ODNs is known to activate immune cells, but its efficacy is sequence-dependent.
- Previous studies indicated pharmacologic activity of certain ODN sequences in vivo.
Purpose of the Study:
- To investigate the ability of single-stranded ODNs to stimulate natural killer (NK) cell cytotoxicity against target cells.
- To compare the stimulatory effects of different ODN sequences, backbones, and modifications on immune cells.
- To evaluate the in vivo immune-activating potential of potent ODN sequences.
Main Methods:
- Isolation of NK cells from murine spleens for in vitro functional assays.
- Testing various single-stranded ODN sequences with different backbone chemistries (phosphodiester vs. phosphorothioate).
- Assessment of CpG motif context, cytosine methylation, and 5-position modifications on ODN activity.
- In vitro B cell proliferation assays to compare with NK cell activation.
- In vivo administration of selected ODNs to assess immune cell activation.
Main Results:
- CpG motif stimulation was highly dependent on specific ODN sequence contexts.
- Phosphorothioate backbones were generally less stimulatory for NK cells than phosphodiester backbones.
- Cytosine modifications (methylation, 5-bromo, 5-iodo) reduced or eliminated CpG-mediated NK cell stimulation.
- Phosphorothioate backbones were required for B cell proliferation, and CpG context was less critical.
- A potent ODN demonstrated in vivo activation of both NK and B lymphocytes.
Conclusions:
- ODN-mediated immune cell activation is critically dependent on sequence context and backbone chemistry.
- Cytosine modifications can significantly attenuate or abolish the immunostimulatory effects of ODNs.
- Specific ODN sequences can activate both NK and B cells in vitro and in vivo, highlighting their therapeutic potential.